Camptothecin
-
Identifiers
CAS number
7689-03-4Molecular formula
C20H16N2O4SMILES
CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O
Safety labels
Acute Toxic
Health -
Odor profile
Fragrance Odorless 48.26% Sweet 32.63% Vanilla 25.26% Fruity 24.31% Powdery 24.1% Bitter 23.63% Burnt 22.13% Grape 21.25% Milky 20.84% Caramellic 20.68% Flavor Bitter 97.46% Odorless 23.72% Bland 22.12% Sweet-like 19.52% Cedarleaf 18.97% Lovage 18.33% Indole 17.82% Very strong 17.78% Parsley 17.61% Nitrile 17.61% Odor impact est.
Low -
Properties
XLogP3-AA
1.0pKa est.
4.67 (weak acid)Molecular weight
348.4 g/molVapor pressure est.
- hPa @ 20°C
- hPa @ 25°C
Evaporation rate
Ultra slowBoiling point est.
1156°CMelting point expt.
- 275-277 °C
Flash point
- 272.07 ˚C est.
-
Synonyms
- camptothecin
- Camptothecine
- 7689-03-4
- (S)-(+)-Camptothecin
- (+)-Camptothecin
- d-Camptothecin
- 20(S)-Camptothecine
- (+)-Camptothecine
- 21,22-Secocamptothecin-21-oic acid lactone
- NSC94600
- NSC-94600
- XT3Z54Z28A
- DTXSID0030956
- (4S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- (19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
- CHEBI:27656
- 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)-
- (4S)-4-ETHYL-4-HYDROXY-1H-PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLINE-3,14(4H,12H)-DIONE
- (19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo(11.8.0.02,11.04,9.015,20)henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
- 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)-
- 20-(S)-camptothecine
- RefChem:388854
- DTXCID8010956
- 21, 22-Secocamptothecin-21-oic acid lactone
- (S)-4-ethyl-4-hydroxy-1H-pyrano-(3',4':6,7)indolozino(1,2-b)quinoline-3,14(4H,12H)-dione
- 1H-Pyrano(3',3'.6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4hydroxy-(S)-
- Campathecin
- MFCD00081076
- (S)-4-ethyl-4-hydroxy-1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- Camptothecine (S,+)
- CHEMBL65
- MLS000766223
- (19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione
- M01564
- (S)-4-ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
- (s)-camptothecine
- (S)-Camptothecin
- 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (4S)-
- 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (4S)-
- 20(S)-Camptothecin
- 4-ETHYL-4-HYDROXY-1,12-DIHYDRO-4H-2-OXA-6,12A-DIAZA-DIBENZO[B,H]FLUORENE-3,13-DIONE
- SR-01000075798
- SR-01000597379
- d-camptothecine
- (S)-4-ethyl-4-hydroxy-1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione
- (S)-4-Ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14-(4H,12H)-dione
- Prestwick_102
- Camptothecine (8CI)
- Spectrum_000299
- Tocris-1100
- SpecPlus_000712
- Prestwick0_000200
- Prestwick1_000200
- Prestwick2_000200
- Prestwick3_000200
- Spectrum2_000903
- Spectrum3_001203
- Spectrum4_000738
- Spectrum5_001126
- CAMPTOTHECIN [MI]
- Lopac-C-9911
- SCHEMBL6038
- UNII-XT3Z54Z28A
- Lopac0_000341
- BSPBio_000159
- BSPBio_002586
- KBioGR_001036
- KBioSS_000779
- KBioSS_002283
- cid_24360
- CAMPTOTHECIN [WHO-DD]
- DivK1c_000826
- DivK1c_006808
- SPECTRUM1502232
- SPBio_000746
- SPBio_002080
- BPBio1_000175
- CCRIS 8162
- orb1309690
- SCHEMBL29351099
- SCHEMBL29360250
- HMS502J08
- KBio1_000826
- KBio1_001752
- KBio2_000779
- KBio2_003347
- KBio2_005915
- KBio3_002086
- 4-Ethyl-4-hydroxy-1H-pyrano-[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- NINDS_000826
- Bio1_000400
- Bio1_000889
- Bio1_001378
- GLXC-10346
- HMS1568H21
- HMS1921N08
- HMS2089F08
- HMS2095H21
- HMS3261E03
- HMS3414J17
- HMS3654D13
- HMS3678J15
- HMS3712H21
- BB_NC-00996
- MSK40312
- Tox21_500341
- AC-202
- BBL033963
- BDBM50008923
- CCG-40255
- EBC-14151
- GR-301
- NSC 94600
- s1288
- STK801886
- AKOS004119861
- Camptothecin; Irinotecan EP Impurity D
- DB04690
- FC15450
- KS-5235
- LP00341
- SDCCGMLS-0066688.P001
- SDCCGSBI-0050329.P003
- BRN 0631069
- CAS-2114454
- IDI1_000826
- NCGC00015290-01
- 7689-03-4
-
Applications
Camptothecin (CAS 7689-03-4) is a natural alkaloid primarily used as a pharmaceutical lead compound in anticancer drug development targeting topoisomerase I, and as the starting point for semi-synthetic derivatives such as topotecan and irinotecan. It is also used as a reference reagent in topoisomerase I mechanism studies and basic mechanistic work, and as a synthetic intermediate to access camptothecin derivatives. Additionally, camptothecin is used in laboratory research and in structure-activity relationship (SAR) evaluations of derivatives to optimize medicinal chemistry properties. In manufacturing and supply chains, it is sourced as a natural product and used as reference material for large-scale synthesis and preclinical screening.
gpt-5-nano
-
Solubility @25˚C
Solvent Solubility (g/L) ethanol 0.11 methanol 0.18 isopropanol 0.15 water 0.0 ethyl acetate 1.49 n-propanol 0.15 acetone 1.15 n-butanol 0.25 acetonitrile 0.51 DMF 2.7 toluene 1.36 isobutanol 0.18 1,4-dioxane 2.33 methyl acetate 1.08 THF 3.14 2-butanone 1.37 n-pentanol 0.25 sec-butanol 0.16 n-hexane 0.02 ethylene glycol 0.2 NMP 3.13 cyclohexane 0.03 DMSO 1.58 n-butyl acetate 1.5 n-octanol 0.46 chloroform 1.51 n-propyl acetate 1.24 acetic acid 1.88 dichloromethane 1.91 cyclohexanone 3.79 propylene glycol 0.11 isopropyl acetate 2.04 DMAc 6.51 2-ethoxyethanol 1.44 isopentanol 0.53 n-heptane 0.04 ethyl formate 0.82 1,2-dichloroethane 1.32 n-hexanol 0.4 2-methoxyethanol 2.02 isobutyl acetate 1.23 tetrachloromethane 0.26 n-pentyl acetate 2.55 transcutol 10.75 n-heptanol 0.76 ethylbenzene 0.6 MIBK 2.06 2-propoxyethanol 2.97 tert-butanol 0.35 MTBE 0.45 2-butoxyethanol 3.74 propionic acid 0.62 o-xylene 1.01 formic acid 1.24 diethyl ether 0.47 m-xylene 1.17 p-xylene 0.8 chlorobenzene 1.16 dimethyl carbonate 3.0 n-octane 0.04 formamide 1.74 cyclopentanone 3.66 2-pentanone 1.46 anisole 1.47 cyclopentyl methyl ether 1.23 gamma-butyrolactone 3.86 1-methoxy-2-propanol 1.68 pyridine 3.26 3-pentanone 1.5 furfural 6.68 n-dodecane 0.05 diethylene glycol 3.72 diisopropyl ether 0.39 tert-amyl alcohol 0.32 acetylacetone 5.18 n-hexadecane 0.06 acetophenone 2.8 methyl propionate 1.51 isopentyl acetate 2.53 trichloroethylene 3.75 n-nonanol 0.68 cyclohexanol 0.48 benzyl alcohol 1.56 2-ethylhexanol 0.55 isooctanol 0.94 dipropyl ether 0.72 1,2-dichlorobenzene 1.62 ethyl lactate 1.5 propylene carbonate 2.57 n-methylformamide 0.88 2-pentanol 0.24 n-pentane 0.02 1-propoxy-2-propanol 1.97 1-methoxy-2-propyl acetate 4.75 2-(2-methoxypropoxy) propanol 5.42 mesitylene 0.77 ε-caprolactone 3.16 p-cymene 0.91 epichlorohydrin 4.0 1,1,1-trichloroethane 1.04 2-aminoethanol 0.2 morpholine-4-carbaldehyde 5.75 sulfolane 4.73 2,2,4-trimethylpentane 0.03 2-methyltetrahydrofuran 1.02 n-hexyl acetate 2.21 isooctane 0.03 2-(2-butoxyethoxy)ethanol 5.8 sec-butyl acetate 1.38 tert-butyl acetate 2.98 decalin 0.05 glycerin 0.9 diglyme 12.11 acrylic acid 1.16 isopropyl myristate 1.58 n-butyric acid 1.3 acetyl acetate 3.08 di(2-ethylhexyl) phthalate 2.93 ethyl propionate 1.58 nitromethane 3.99 1,2-diethoxyethane 2.87 benzonitrile 2.08 trioctyl phosphate 1.57 1-bromopropane 0.4 gamma-valerolactone 7.75 n-decanol 0.53 triethyl phosphate 2.07 4-methyl-2-pentanol 0.43 propionitrile 0.71 vinylene carbonate 3.69 1,1,2-trichlorotrifluoroethane 5.24 DMS 3.97 cumene 0.54 2-octanol 0.48 2-hexanone 1.2 octyl acetate 1.65 limonene 0.77 1,2-dimethoxyethane 3.49 ethyl orthosilicate 2.04 tributyl phosphate 1.77 diacetone alcohol 3.5 N,N-dimethylaniline 1.32 acrylonitrile 1.44 aniline 1.39 1,3-propanediol 0.62 bromobenzene 1.26 dibromomethane 0.9 1,1,2,2-tetrachloroethane 2.27 2-methyl-cyclohexyl acetate 2.39 tetrabutyl urea 2.87 diisobutyl methanol 0.73 2-phenylethanol 2.65 styrene 0.62 dioctyl adipate 2.74 dimethyl sulfate 4.49 ethyl butyrate 1.76 methyl lactate 2.0 butyl lactate 2.64 diethyl carbonate 1.91 propanediol butyl ether 1.88 triethyl orthoformate 2.25 p-tert-butyltoluene 0.88 methyl 4-tert-butylbenzoate 6.29 morpholine 1.48 tert-butylamine 0.17 n-dodecanol 0.43 dimethoxymethane 3.33 ethylene carbonate 2.74 cyrene 4.55 2-ethoxyethyl acetate 5.6 2-ethylhexyl acetate 1.84 1,2,4-trichlorobenzene 2.38 4-methylpyridine 2.5 dibutyl ether 0.78 2,6-dimethyl-4-heptanol 0.73 DEF 2.18 dimethyl isosorbide 9.66 tetrachloroethylene 2.16 eugenol 6.77 triacetin 5.06 span 80 3.32 1,4-butanediol 0.27 1,1-dichloroethane 0.66 2-methyl-1-pentanol 0.5 methyl formate 1.11 2-methyl-1-butanol 0.36 n-decane 0.07 butyronitrile 0.59 3,7-dimethyl-1-octanol 0.7 1-chlorooctane 0.32 1-chlorotetradecane 0.2 n-nonane 0.05 undecane 0.06 tert-butylcyclohexane 0.05 cyclooctane 0.03 cyclopentanol 0.36 tetrahydropyran 0.82 tert-amyl methyl ether 0.56 2,5,8-trioxanonane 10.43 1-hexene 0.08 2-isopropoxyethanol 1.42 2,2,2-trifluoroethanol 1.45 methyl butyrate 1.61 Scent© AI
| Maximum acceptable concentrations in the finished product (%) | |||
|---|---|---|---|
|
Category 1
Products applied to the lips
|
No restriction |
Category 7A
Rinse-off products applied to the hair with some hand contact
|
No restriction |
|
Category 2
Products applied to the axillae
|
No restriction |
Category 7B
Leave-on products applied to the hair with some hand contact
|
No restriction |
|
Category 3
Products applied to the face/body using fingertips
|
No restriction |
Category 8
Products with significant anogenital exposure
|
No restriction |
|
Category 4
Products related to fine fragrance
|
No restriction |
Category 9
Products with body and hand exposure, primarily rinse off
|
No restriction |
|
Category 5A
Body lotion products applied to the body using the hands (palms), primarily leave on
|
No restriction |
Category 10A
Household care products with mostly hand contact
|
No restriction |
|
Category 5B
Face moisturizer products applied to the face using the hands (palms), primarily leave on
|
No restriction |
Category 10B
Household care products with mostly hand contact, including aerosol/spray products (with potential leave-on skin contact)
|
No restriction |
|
Category 5C
Hand cream products applied to the hands using the hands (palms), primarily leave on
|
No restriction |
Category 11A
Products with intended skin contact but minimal transfer of fragrance to skin from inert substrate without UV exposure
|
No restriction |
|
Category 5D
Baby Creams, baby Oils and baby talc
|
No restriction |
Category 11B
Products with intended skin contact but minimal transfer of fragrance to skin from inert substrate with potential UV exposure
|
No restriction |
|
Category 6
Products with oral and lip exposure
|
No restriction |
Category 12
Products not intended for direct skin contact, minimal or insignificant transfer to skin
|
No restriction |